Pfizer
06:25 :
Pfizer profit rises 5%, sticks to adj. 2011 view -
NEW YORK (MarketWatch) -- Pfizer Inc. said Tuesday its second-quarter profit climbed to $2.61 billion, or 33 cents a share, from $2.48 billion, or 31 cents a share, in the year-ago period. Adjusted profit at the pharmaceutical company fell ...
02:19 :
Pfizer believers await more reassurance -
Pfizer Inc is expected to report lower quarterly earnings on Tuesday, hurt by competition from generic copies of its Lipitor cholesterol fighter, but investors will focus mainly what the company plans to do after Lipitor faces U.S. generics ...
16:41 :
Earnings Preview: Pfizer to report on 2nd quarter -
TRENTON, N.J. (AP) -- Pfizer Inc., which reports second-quarter results before the stock market opens Tuesday, will discuss a few recent drug approvals, new data on some experimental drugs and plans to divest some of its non-core businesses....
15:01 :
Pfizer seen posting higher profit, but lower sales -
Pfizer Inc., the world’s largest pharmaceutical maker, is expected to post a substantially higher second-quarter profit on August 2 over last year’s quarter, but sales will likely come in a bit lower.
10:47 :
Pfizer to open research center in SF's Mission Bay -
Boosting Mission Bay's goal of becoming a hub for cutting-edge biotech, the world's largest drugmaker today will announce plans to establish a research center there. New York's Pfizer plans to set up its Center for...
01:22 :
Pfizer to buy Icagen for $56M -
Icagen, which was once one of the Triangle's most promising drug-development companies, has agreed to be bought by its larger partner Pfizer for about $56 million.
08:43 :
Icagen plunges on Pfizer takeover terms -
BOSTON (MarketWatch)-- After being bid sky-high in anticipation of a merger deal, shares of
Icagen Inc. plunged 23% to $5.96 in premarket trading Wednesday on news that Pfizer Inc. plans to buy the biotech group for $6 a share. ...
13:23 :
Pfizer May Unload Businesses Worth More Than $16B -
Pfizer, the world's biggest drugmaker, may sell or spin off units valued at more than $16 billion to focus on its main pharmaceutical business and dampen the blow from the loss of its top-selling Lipitor cholesterol medication. #xD; #xD;
08:06 :
Pfizer to sell animal health, nutitrition units -
BOSTON (MarketWatch) -- As part of a previously-announced strategic review, pharmaceutical
titan Pfizer Inc. said early Thursday that it is seeking to sell its animal health-care and nutritional products units. The Animal ...
07:22 :
Pfizer anti-smoking drug tied to heart risk:report -
NEW YORK (MarketWatch) -- Pfizer Inc.s Chantix, a drug used to help cigarette smokers give up the habit, has been linked to a 72% increase in the risk of heart problems including stroke and congestive heart failure, according to a report ...
11:22 :
Pfizer Drug Is Linked to Heart Problems -
Pfizer's smoking-cessation drug Chantix was linked to a 72% increase in cardiovascular problems, including stroke and congestive heart failure, according to a new analysis of medical studies.
08:58 :
Icagen rockets 130% on Pfizer talks -
BOSTON (MarketWatch) -- Shares of
Icagen Inc. rocketed a litte over 130% to $5.58 early Monday on Friday's news that the company and Pfizer Inc. are in talks over a possible merger or expansion of their existing collaboration. ...
03:44 :
Icagen talks with Pfizer about takeover -
Icagen, a Durham drug-development company that has struggled financially, is in discussions about a possible takeover by its much-larger partner Pfizer.
actualidad Pfizer -